HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisa D Hisaw Selected Research

Papulosquamous Skin Diseases (Papulosquamous Disorders)

11/2017Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisa D Hisaw Research Topics

Disease

3Pityriasis Rubra Pilaris
01/2019 - 11/2017
1Localized Scleroderma (Morphea)
06/2019
1Acne Vulgaris
12/2017
1Papulosquamous Skin Diseases (Papulosquamous Disorders)
11/2017

Drug/Important Bio-Agent (IBA)

2Ustekinumab (CNTO 1275)FDA Link
09/2018 - 11/2017
1pembrolizumabIBA
06/2019
1apremilastIBA
01/2019
1secukinumabIBA
09/2018
1Tumor Necrosis Factor InhibitorsIBA
09/2018
1Small Interfering RNA (siRNA)IBA
12/2017
1EnzymesIBA
12/2017
1ImmunosorbentsIBA
12/2017
1Isotretinoin (Accutane)FDA LinkGeneric
12/2017
1Adalimumab (Humira)FDA Link
11/2017
1Etanercept (Enbrel)FDA Link
11/2017
1RetinoidsIBA
11/2017